Related Experiment Video
Updated: Jan 27, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Biological Evaluation and Molecular Docking Studies of Dimethylpyridine Derivatives
Piotr Świątek1, Katarzyna Gębczak2, Tomasz Gębarowski3
1Department of Chemistry of Drugs, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland. piotr.swiatek@umed.wroc.pl.
Abstract:
Cyclooxygenase inhibitors as anti-inflammatory agents can be used in chemoprevention. Many in vitro and in vivo studies on human and animal models have explained the mechanisms of the chemopreventive effect of COX inhibitors such as: induction of apoptosis, inhibition of neoplasia, angiogenesis suppression, induction of cell cycle inhibition and inhibition of the expression of peroxisome proliferator-activated receptors. Here, biological evaluation of twelve different Schiff base derivatives of N-(2-hydrazine-2-oxoethyl)-4,6-dimethyl-2-sulfanylpyridine- 3-carboxamide are presented. Their in vitro anti-COX-1/COX-2, antioxidant and anticancer activities were studied. The molecular docking study was performed in order to understand the binding interaction of compounds in the active site of cyclooxygenases. Compounds PS18 and PS33 showed a significant inhibitory activity on COX-1 at lower concentrations compared to meloxicam and piroxicam. The IC50 of COX-1 of these compounds was 57.3 µM for PS18 and 51.8 µM for PS33. Out of the tested compounds, the highest therapeutic index was demonstrated by PS18, PS19, PS33, PS40 and PS41. Lower molar concentrations of these compounds inhibit the growth of cancer cells while not inhibiting the healthy cells. Compounds PS18, PS19 and PS33 simultaneously demonstrated a statistically-significant inhibition of COX-1 or COX-2. This opens up the possibility of applying these compounds in the chemoprevention of cancer.
Insights
New Schiff base derivatives show promise as anti-cancer agents by inhibiting cyclooxygenase enzymes (COX-1/COX-2). These compounds exhibit significant anticancer activity with a high therapeutic index, suggesting potential for cancer chemoprevention.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Research
Background:
- Cyclooxygenase (COX) inhibitors are recognized for their anti-inflammatory properties and potential in cancer chemoprevention.
- Established mechanisms include apoptosis induction, neoplasia inhibition, angiogenesis suppression, cell cycle arrest, and PPAR expression modulation.
- Schiff base derivatives represent a class of compounds with diverse biological activities.
Purpose of the Study:
- To synthesize and biologically evaluate novel Schiff base derivatives of N-(2-hydrazine-2-oxoethyl)-4,6-dimethyl-2-sulfanylpyridine-3-carboxamide.
- To assess the in vitro anti-COX-1/COX-2, antioxidant, and anticancer activities of these derivatives.
- To investigate the binding interactions within the cyclooxygenase active sites using molecular docking.
Main Methods:
- Synthesis of twelve novel Schiff base derivatives.
- In vitro assays for COX-1 and COX-2 inhibition, antioxidant capacity, and anticancer activity against cancer cell lines.
- Molecular docking studies to elucidate binding modes with cyclooxygenase enzymes.
Main Results:
- Compounds PS18 and PS33 exhibited significant COX-1 inhibitory activity, surpassing that of meloxicam and piroxicam at lower concentrations (IC50 values of 57.3 µM and 51.8 µM, respectively).
- Compounds PS18, PS19, PS33, PS40, and PS41 demonstrated the highest therapeutic index, selectively inhibiting cancer cell growth without affecting healthy cells.
- Compounds PS18, PS19, and PS33 showed statistically significant inhibition of either COX-1 or COX-2.
Conclusions:
- The novel Schiff base derivatives possess significant potential as anticancer agents due to their COX inhibitory and selective cytotoxic effects.
- Compounds PS18, PS19, and PS33 are particularly promising candidates for further development in cancer chemoprevention strategies.
- The findings support the exploration of these derivatives for therapeutic applications targeting inflammatory pathways in cancer.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
10:22Use of the TetON System to Study Molecular Mechanisms of Zebrafish Regeneration
Published on: June 25, 2015
Related Concept Videos
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy
What is Conservation Biology?
Molecular Models
Real Gases: Effects of Intermolecular Forces and Molecular Volume Deriving Van der Waals Equation
Biological Effects of Radiation
Molecular Orbital Theory II